Generic (active ingredient)Registered with DGDA
Tipiracil + Trifluridine: brands in Bangladesh
The DGDA registry lists 5 registered products with the generic Tipiracil + Trifluridine, under 5 brand names from 3 companies.
Dosage forms: Tablet. Strengths: 6.14 mg + 15 mg, 8.19 mg + 20 mg.
Registered Tipiracil + Trifluridine products
Grouped by strength and dosage form. For information only; this is not a recommendation to substitute one product for another.
6.14 mg + 15 mg · Tablet (3 products)
| Brand | Company | DAR no. |
|---|---|---|
| Loncil 15/6.14 | Beacon Pharmaceuticals PLC | 341-0621-010 |
| Triflucil 15 F.C Tablet | Renata PLC | 353-0431-010 |
| Trifluxen | Everest Pharmaceuticals Ltd. | 157-0241-010 |
8.19 mg + 20 mg · Tablet (2 products)
| Brand | Company | DAR no. |
|---|---|---|
| Loncil 20/8.19 | Beacon Pharmaceuticals PLC | 341-0622-010 |
| Triflucil 20 F.C Tablet | Renata PLC | 353-0432-010 |
Dosage forms available
Each link lists all registered medicines in that dosage form.
Top companies for Tipiracil + Trifluridine
Companies with the most registered Tipiracil + Trifluridine products.
- Beacon Pharmaceuticals PLC2 products
- Renata PLC2 products
- Everest Pharmaceuticals Ltd.1 product
Related generics
Single ingredients in this combination
Frequently asked questions
How many Tipiracil + Trifluridine brands are registered in Bangladesh?
In which dosage forms and strengths is Tipiracil + Trifluridine registered?
Which companies have the most registered Tipiracil + Trifluridine products?
Can one Tipiracil + Trifluridine brand be used instead of another?
About this data
Source: DGDA Registered Drug Products (Directorate General of Drug Administration (DGDA), via DGHS national terminology server), retrieved 4 Oct 2026. “Registered” means the product appears in the official registry; it does not confirm current availability or price. Prices are not shown because no verified price source exists yet.
This site provides general medicine and price information only. It is not medical advice. Do not start, stop or change any medicine without consulting a qualified healthcare professional.